Keywords: altana, moving, roflumilast, into, ph, iii, german

Altana moving roflumilast into Ph III

Article | 17 August 2001

Print This

German drugmaker Altana AG says that its novel asthma therapyroflumilast is about to move into Phase III trials, which led ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in